Sobre la Empresa
- Nombre legal: Guangdong Raffles PharmaTech Co Ltd
- País de registro: China
- Dirección: No 3, Binhai 10th Road North, Shihua Dadao Middle, Daya Bay, Huizhou, Guangdong
- Número de empleados: 250 - 499
Descripción:
Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceutical ingredients and intermediates. We are specialized in applying organic catalysts into the process development to lower cost, and to provide cost-effective product and service to customers. With our strong R&D capability and our proprietary organic catalysts, we provide low cost and high quality active pharmaceutical ingredients and intermediates to pharmaceutical companies. We also provide world standard process development, custom synthesis and manufacturing service.
Actividades Comerciales
Ingredientes Farmacéuticos Activos (API)
Fabricante
Servicios de contratación y externalización
Fabricante
Químicos Farmacéuticos
Fabricante
Servicios de Organizaciones de Investigación por Contrato (CRO)
Fabricante
Servicios Biofarmacéuticos
Fabricante
Mercados de Venta
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
Productos/Servicios Clave
- Químicos Farmacéuticos: (2R,6R)-2,6-diphenyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2R)-2-Piperidine Methanamine, (3S,11aR)-N-(2,4-difluorobenzyl)-6-methoxy-3-methyl-5,7, (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, 1,5,7-Triazabicyclo[4.4.0]dec-5-ene, 1,4,6-Triazabicyclo[3.3.0]oct-4-ene, (4S,5S)-1H-lmidazolium,2- [[(4S,5S)-1,3-dimiethyl-4,5, (S)-a-(Phenylmethyl)-1-pyrrolidinethanamine, (R)-VAPOL HYDROGENPHOSPHATE, (8a,9R)- 10,11-dihydro-Cinchonan-6',9-diol, (9S)-9-(9-phenanthrenyloxy)-Cinchonan-6'-ol, (S)-(–)-a,a-Diphenyl-2-pyrrolidinemethanol trimethylsilyl ether, 2-(diphenylphosphino)-N-(pyridin-2-ylmethyl)ethanamine, (S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H- [1,2,4], (5aR,10bS)-(+)-5a,10b-Dihydro-2-(pentafluorophenyl, (5aS, 10bR)-(-)-5a,10b-Dihydro-2-(pentafluorophe, 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, (S)-5-benzyl-2-phenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c], (S)-2-[[(1R,2R)-2-AMINOCYCLOHEXYL]THIOUREIDO] -N-BENZYL-N,3,3-TRIMETHYLBUTANAMIDE, (2S)-2-[[[[3,5-Bis(trifluoromethyl) phenyl]amino], 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1R,2R)-2-(dimethylamino)cyclohexyl]thiourea, (2S)-2-amino-N,3,3-trimethyl-N-(phenylmethyl)-ButaN/Amide, (S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl) -3-((1R,2R)-2-(dipropylamino)cyclohexyl)thiour, 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1S,2S)-2-(dimethylamino)cyclohexyl]thiourea, (S)-2-[[(1R,2R)-2-[[[3,5-Bis(tert-butyl)-2-hydroxyphenyl] methylene]amino]cyclohexyl]thioureido], 2-Propanesulfinamide, N-[(1R,2R)-2-[[[[3,5-bis(trifluoromethyl)phenyl]amino] carbonyl]amino]cycloh, (2S)-3,3-DIMETHYL-2-[[(1R,2R)-2-(2-METHYL-5-PHENYL-1-PYRROLYL) CYCLOHEXYL]THIOUREIDO]-N,N-BIS(2-ISO, (R,R)-(+)-Hydrobenzoin, (2S)-2-Piperidine Methanamine, (2S,3S,4S,5R,6R)-6-bromotetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate, (3S)-3-Thiophenamine, tetrahydro-, 1,1-dioxide, hydrochloride (1:1), (2S,3R)-2-hydroxy-3-(naphthalen-2-ylmethyl)succinic acid1, (R)-2-((S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl) -3-(naphthalen-2-yl)propanoic acid, (S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1-naphthalenone, 1,4-difluoroanthraquinone
Nuestros Productos & Servicios
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario